Patients with HAM/TSP that harbor the transcontinental subgroup of HTLV-1 are reported to exhibit lower levels of HBZ mRNA expression [25] and higher levels of CXCL10, which has been suggested as a potential prognostic biomarker for HAM/TSP [26]. The gene discussed is CXCL10; the disease is tropical spastic paraparesis.